AI assistant
Alkemy — Investor Presentation 2021
May 14, 2021
4397_er_2021-05-14_e4d178b0-278a-4804-9823-a8b8a0e45e4a.pdf
Investor Presentation
Open in viewerOpens in your device viewer

1Q 2021 RESULTS
14.05.2021

Disclaimer
- This document has been prepared by Alkemy S.p.A. (the "Company") for information purpose only, it contains only summary information and, therefore, it is preliminary in nature. Furthermore it has been drafted without claiming to be exhaustive.
- This presentation ("Presentation") and the information set out herein ("Information") are strictly confidential and, as such, has not been prepared with a view to public disclosure and, except with the prior written consent of the Company, it cannot be used by the recipient for any purpose nor can it be disclosed, copied, recorded, transmitted, further distributed to any other person or published, in whole or in part, by any medium or in any form for any purpose.
- This Presentation may contain financial information and/or operating data and/or market information regarding business and assets of the Company and its subsidiaries. Certain financial information may not have been audited, reviewed or verified by any independent accounting firm.
- Therefore, the recipient undertakes vis-à-vis the Company (i) to keep secret any information of whatever nature relating to the Company and its affiliates including, without limitation, the fact that the information has been provided, (ii) not to disclose any Information to anyone, (iii) not to make or allow any public announcements or communications concerning the Information and (iv) to use reasonable endeavours to ensure that Information are protected against unauthorized access.
- THIS PRESENTATION AND ANY RELATED ORAL DISCUSSION DO NOT CONSTITUTE AN OFFER TO THE PUBLIC OR AN INVITATION TO SUBSCRIBE FOR, PURCHASE OR OTHERWISE ACQUIRE ANY FINANCIAL PRODUCTS, AS DEFINED UNDER ARTICLE 1, PARAGRAPH 1, LETTER (T) OF LEGISLATIVE DECREE NO. 58 OF 24 FEBRUARY 1998, AS AMENDED. Therefore, this document is not an advertisement and in no way constitutes a proposal to execute a contract, an offer or invitation to purchase, subscribe or sell for any securities and neither it or any part of it shall form the basis of or be relied upon in connection with any contract or commitment or investments decision whatsoever. The Company has not prepared and will not prepare any prospectus for the purpose of the initial public offering of securities. Any decision to purchase, subscribe or sell for securities will have to be made independently of this Presentation. Therefore, nothing in this Presentation shall create any binding obligation or liability on the Company and its affiliates and any of their advisors or representatives.
- Likewise, this Presentation is not for distribution in, nor does it constitute an offer of securities for sale in the United States of America, Canada, Australia, Japan or any jurisdiction where such distribution is unlawful, (as such term is defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act"). Neither this Presentation nor any copy of it may be taken or transmitted into the United States of America, its territories or possessions, or distributed, directly or indirectly, in the United States of America, its territories or possessions or to any US person. Any failure to comply with this restriction may constitute a violation of United States securities laws.
- No representation or warranty, express or implied, is or will be given by the Company as to the accuracy, completeness or fairness of any Information provided and, so far as is permitted by law and except in the case of fraud by the party concerned, no responsibility or liability whatsoever is accepted for the accuracy or sufficiency thereof or for errors, omissions or misstatements, negligent or otherwise, relating thereto. In particular, but without limitation, no representation or warranty, express or implied, is or will be given as to the achievement or reasonableness of, and no reliance may be placed for any purpose on the accuracy or completeness of, any estimates, targets, projections or forecasts and nothing in these materials should be relied upon as a promise or representation as to the future.
- The information and opinions contained in this document are provided as at the date hereof and are subject to change without notice. The recipient will be solely responsible for conducting its own assessment of the information set out in the Presentation. Neither the Company and its affiliates, nor any of their advisors or representatives shall be obliged to furnish or to update any information or to notify or to correct any inaccuracies in any information. Neither the Company and its affiliates, nor any of their advisors or representatives shall have any liability to the recipient or to any of its representatives as a result of the use of or reliance upon the information contained in this document.
- Certain Information may contain forward-looking statements which involve risks and uncertainties and are subject to change. In some cases, these forward-looking statements can be identified by the use of words such as "believe", "anticipate", "estimate", "target", "potential", "expect", "intend", "predict", "project", "could", "should", "may", "will", "plan", "aim", "seek" and similar expressions. The forecasts and forward-looking statements included in this document are necessarily based upon a number of assumptions and estimates that are inherently subject to significant business, operational, economic and competitive uncertainties and contingencies as well as assumptions with respect to future business decisions that are subject to change. By their nature, forward-looking statements involve known and unknown risks and uncertainties, because they relate to events, and depend on circumstances, that may or may not occur in the future. Furthermore, actual results may differ materially from those contained in any forward-looking statement due to a number of significant risks and future events which are outside of the Company's control and cannot be estimated in advance, such as the future economic environment and the actions of competitors and others involved on the market. These forward-looking statements speak only as at the date of this Presentation. The Company cautions you that forward looking-statements are not guarantees of future performance and that its actual financial position, business strategy, plans and objectives of management for future operations may differ materially from those made in or suggested by the forward-looking statements contained in this Presentation. In addition, even if the Company's financial position, business strategy, plans and objectives of management for future operations are consistent with the forward-looking statements contained in this Presentation, those results or developments may not be indicative of results or developments in future periods. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
- By receiving this Presentation, you acknowledge and agree to be bound by the foregoing terms, conditions, limitations and restrictions.

WE DESIGN BUSINESS EVOLUTION THROUGH DATA, TECHNOLOGY & CREATIVITY

Alkemy was founded in 2012 with the aim of supporting the top management of large companies in the process of digitizing their business model.
The market in which Alkemy insists is the digital transformation market which today is worth over 6 billion euros in Italy and grows at a rate of between 7 and 10% per year.
In this market, Alkemy has developed a differentiated positioning that has allowed it to grow with a CAGR of 33% (>2x the market), to move from the 23 starting resources to a team of over 650 people and a turnover of 74.9M€.
In these 8 years, Alkemy has successfully used the M&A lever (8 acquisitions) using the IPO proceeds in less than nine months, and the EBITDA growth of the four acquisitions made in Italy from 2013 to 2018 was between 70 and 500%.
Alkemy has developed a new organization and a new Go-to-Market strategy that have laid the foundations for the industrialization and expansion of the business scale, resulting in strong organic growth and higher marginality.
We help companies to evolve their business in the post-digital scenario

1Q 2021 – BACK TO ORGANIC GROWTH AND MARGIN EXPANSION
-
Organic growth back to positive, up by +7% compared to 1Q 2020
-
Strong improvement in marginality compared to 1Q 2020 (+8pps)
-
New Business activity & growth of TOP 50 clients' revenues
-
Positive cash generation over the period (€M 1.9 operative cash flow)
-
Positive Group Result of €M 0.5

The industrialization of business model strengthens marginality and boosts organic growth

1Q 2021
FINANCIAL HIGHLIGHTS
| €M | 1Q 2021 | 1Q 2020 | |
|---|---|---|---|
| Turnover | 20.7 | 19.3 | +7% compared to 1Q 2020, thanks to a first recovery of new > business activities, and the new Go-to-Market highly focused on main clients' projects |
| Adj. EBITDA | 2.0 | 0.3 | +532% compared to 1Q 2020, thanks to the better mix and > efficiencies arising from the new organization. EBITDA margin up by + 8 pps |
| EBIT | 1.1 | (0.1) | Strong growth compared to 1Q 2020, thanks to the better > operating result. EBIT margin up by +5.6 pps |
| EBT | 0.8 | (0.5) | Positive result compared to 1Q 2020, thanks to the better > performance over the period and lower financial charges |
| Group Net Income |
0.5 | (0.5) | The positive result is achieved thanks to the better > operative result and to the efficiencies arising from the new organization |
| Operating Cash Flow |
1.9 | (0.4) | Increase of €M 2.3 compared to 1Q 2020 mainly thanks to > the better operating result |
| NFP | -12.4 | FY 2020 -12.4 |
Variation since 31 December 2020 of €M -0.01 mostly due > to: €M +0.7 in cash liquidity, €M +0.7 decrease in financial debt, €M – 1.4 increase in leasing (IFRS 16) |

-
+7% compared to 1Q 2020, thanks to a first recovery of new business activities, and the new Go-to-Market highly focused on main clients' projects
-
+532% compared to 1Q 2020, thanks to the better mix and efficiencies arising from the new organization. EBITDA margin up by + 8 pps
- operating result. EBIT margin up by +5.6 pps
- performance over the period and lower financial charges
-
The positive result is achieved thanks to the better operative result and to the efficiencies arising from the new
- the better operating result
-
Variation since 31 December 2020 of €M -0.01 mostly due to: €M +0.7 in cash liquidity, €M +0.7 decrease in financial debt, €M – 1.4 increase in leasing (IFRS 16)
1Q REVENUES(€M) – IAS /IFRS

REVENUES
(1)Revenues 2013-14-15-16 are Management estimates and are not audited, following the introductions of IFRS in 2018.

› 1Q 2021 revenues are €M20.7, +7% compared to 1Q 2020 which were €M19.3,

› 1Q 2021 Italian turnover is €M 14.0 up by 4% compared to €13.5 M in 1Q 2020. Top 50 clients overperformed over the period. Recovery of New Business

- going back to organic growth.
- activity
- Spain.

› International revenues in 1Q 2021 are €M 6.7, up by 14% vs. €M 5.8 in 1Q 2020, partially recovering from COVID-19 related decline in 2020, especially in
FY REVENUES (€M) – IAS /IFRS (1)
BACK TO ORGANIC GROWTH
1Q ALKEMY Adj. EBITDA(€M) – IAS/IFRS
(1)Ebitda margin is calculated relating the EBITDA to the revenues of the period
(2()Ebitda margin net media is calculated relating the EBITDA to the revenues of the period net of Media related revenues from Spain and Mexico companies
1Q EBITDA MARGIN – EBITDA MARGIN NET MEDIA (%)(1)(2)
› 1Q 2021 EBITDA is €M2.00, +532% compared to 1Q 2020 of €M 0.3, thanks to the better mix of the new Go-to-Market strategy and the efficiency and razionalizati0n of the new organization.
Adj. EBITDA CONSISTENT IMPROVEMENT IN MARGINALITY

- › EBITDA Margin is 9.6% in 1Q 2021 vs 1.6% in 1Q 2020 with a positive growth of 8 pps, thanks to lower costs impact on revenues, thanks to the industrialization process started in 2020
- › EBITDA Margin net media is 11.4% in 1Q 2021 vs. 2.0% in 1Q 2020



FY ALKEMY Adj. EBITDA(€M) – IAS/IFRS

NET FINANCIAL POSITION BRIDGE AND DETAILS
Net Financial Position Bridge 1Q 2021 (€M)


NET TRADE WORKING CAPITAL DYNAMICS
-
1Q 2021 Net Trade Working capital 6% higher than 1Q 2020
-
The cash generation from Net Trade Working Capital decrease (€M +1.8 million) was more than 2 times higher in comparison to 1Q 2020, thanks to payables and receivables dynamics
-
1Q 2021 DSO -11% vs. 1Q 2020; 1Q 2021 DPO -29% vs. 1Q 2020


FY 2018 1H 2019 FY 2019 1Q 2020 1H 2020 9M 2020 FY 2020 1Q 2021

Cash Conversion Cycle Details (days)
1Q 2021 P&L – IAS/IFRS
› 1Q 2020 Revenues at €M 20.7, up by 7% compared to €M 19.3 of 1Q 2020. The increase is mostly attributable to the recovery of New Business activities and the strong focus on main clients. Italian revenues up by 4% yoy, mainly thanks to the new Go-to-Market strategy. Foreign turnover up by 14%, mainly thanks to Spain's subsidiary, which overperformed over the period compensating Mexico's slower recovery.
› Operative costs decreased by -0.5% yoy, reducing the impact on revenues by 6% compared to 1Q 2020. Services costs decreased by 10% yoy. This efficiency is mostly achieved thanks to the actions taken to internalize tech activities. Personnel costs increased incidence on revenues by 4% compared to 1Q 2020, attributable to the higher FTE for the period.
› 1Q 2021 Adj. EBITDA at €M 2.0 +532% compared to €M 0.3 in 1Q 2020, with a margin increase of 8 pps (EBITDA margin 9.6%). EBIT is equal to €M 1.1 higher than €M 0.1 in 1Q 2020, with an increase of 7.7 pps in EBIT margin.
› Financial charges decreased from €M 0.4 in 1Q 2020 to €M 0.2. in 1Q 2021 EBT positive for €M 8.4. 1Q 2021 Group Net Result is €M 0.5 vs €M -0.5 in 1Q
-
- 2020.

Consolidated Profit & Loss
| Profit and Loss (€000) - IAS/IFRS | 16 2020 1 0 202 | |
|---|---|---|
| Revenues | 19.326 | 20.655 |
| Service costs, consum. & goods | (11.885) | (10.677) |
| Personnel | (7.128) | (8.423) |
| EBITDA | 313 | 1.555 |
| % Revenues | 1,6% | 7,5% |
| Non recurrent costs | O | (424) |
| Adj. EBITDA | 313 | 1.979 |
| % Revenues | 1,6% | 9,6% |
| D&A | (413) | (445) |
| Bad debts/ claims/ provisions | (3) | (રક) |
| EBIT | (103) | 1.051 |
| % Revenues | -0,5% | 5,1% |
| Financial charges | (423) | (210) |
| EBT | (526) | 841 |
| Taxes | (62) | (356) |
| % Tax rate | -11,8% | 42,3% |
| Net Profit (Loss) | (288) | 485 |
| o/w Minorifies | (101) | (3) |
| o/w Group Net Profit (Loss) | (487) | 488 |
1Q 2021 BALANCE SHEET – IAS/ IFRS
› Net Invested Capital at €M 44.3 (€M 44.0 at FY 2020) and consisted of approx. € 14.5 million of Net Trade Working Capital (€M 16.4 FY 2020), €M 42.1 of fixed assets (€M 41.0 FY 2020) of which €M 31.7 of Goodwill and €M 4.6 of rights of use (IFRS 16), and €M 5.1 of final Employees' leaving entitlement.
› Shareholders' equity increased in the period by €M 0.5 since 31 dec. 2020 (+1.6%), thanks to the positive result of the
- period

› Net Financial Position at March 30th 2021 negative for €M - 12.4 (ante-IFRS 16 at €M -7.4) mostly stable compared to the negative Net Financial Position at 31 December 2020.
Consolidated Balance Sheet
| Balance Sheet (€000) - IAS/IFRS | 2020 Ter 2021 | |
|---|---|---|
| Tangible assets | 855 | 865 |
| Intagible assets | 7.093 | 8.406 |
| o/w rights of use (IFRS16) | 3.122 | 4.555 |
| Goodwill | 31.755 | 31.754 |
| Financial assets | 1.174 | 1.095 |
| Fixed Assets | 40.877 | 42.120 |
| Inventories | O | O |
| Trade Receivables | 31.044 | 28.411 |
| Trade Payables | (14.688) | (13.926) |
| Net Trade Working Capital | 16.356 | 14.485 |
| Other Current Assets | 4.207 | 3.991 |
| Other Current Liabilities | (12.579) | (11.203) |
| Employees' leaving entitlement | (5.087) | (5.108) |
| Total Capital Invested | 43.774 | 44.285 |
| Total Equity | 31.396 | 31.895 |
| o/w Group Equity | 31.142 | 31.645 |
| o/w Minorities | 254 | 250 |
| Cash & current financial assets | (18.922) | (19.676) |
| Bank Debts | 16.071 | 15.336 |
| Put Option Liabilities | 12.038 | 12.093 |
| Other Financial Debts (IFRS16) | 3.191 | 4.637 |
| Net Debt (Cash) | 12.378 | 12.390 |
| Total Funds | 43.774 | 44.285 |
1Q 2021 CASH FLOW GENERATION – IAS/IFRS
› 1Q 2021 Gross Cash Flow at €M 1.7, compared to €M 0.5 in 1Q 2020. The increase yoy is mostly due to the positive result of the
› 1Q 2021 Operating cash flow at €M 1.9 compared to €M -0.4 of 1Q 2020. The positive variation is mostly due to the better
- period.
- operating result.

› Ordinary Capex of the period are 24% lower than 1Q 2020. 1Q 2021 Free Cash Flow before Acquisitions is equal to €M 1.8, compared to €M -0.5 of 1Q 2020.
› 1Q 2020 Free Cash Flow is €M 1.8, showing a strong improvement compared to 1Q 2020 €M -0.5.
› Total change in cash for the period was €M 0.8 compared to €M 1.4, mostly due to the decrease in financial debts.
Consolidated Cash Flow
| Cash Flow Statement (€000) - IAS/IFRS | 1Q 2020 1Q 2021 | |
|---|---|---|
| Net Profit (Loss) | (288) | 485 |
| Adjustments (cash tax, interest and other) | 485 | 566 |
| Non cash items | 594 | 640 |
| Gross Cash Flow | 491 | 1.691 |
| Change in inventories | 31 | O |
| Change in trade receivables | 1.951 | 2.581 |
| Change in trade payables | (1.127) | (762) |
| Total change in NTWC | 855 | 1.819 |
| Total change in other asset/liabilities | (1.736) | (1.618) |
| Operating Cash Flow | (390) | 1.892 |
| Capex | (103) | (135) |
| Free Cash Flow before Acquisition | (493) | 1.757 |
| Other financial assets | 37 | રેર |
| Free Cash Flow | (456) | 1.813 |
| Change in treasury shares | O | 0 |
| Dividends to minorities | (162) | 0 |
| Change in bank & fin. Debts | 2.386 | (789) |
| IFRS 16 effect | (230) | (270) |
| Changes in equity | O | |
| Change in put/option | (90) | 0 |
| Change in Cash | 1.448 | 754 |
| Initial Cash | 9.581 | 18.840 |
| Final Crich | 11 029 | 10 50 4 |
LOOKING AHEAD
-
In light of the positive trend of results achieved in the last months of 2020 and confirmed in the first quarter of 2021, considering the current size of orders and contracts portfolio and the general favorable progress of the business, barring the occurrence of further unforeseeable negative events related to the pandemic, management's expectation of a resumption of organic growth is confirmed, both in terms of revenues and mostly of margins.
-
The management expected, indeed, the full recovery of the New Business activity in the following months, which effects will be registered already in 2Q 2021, and to further benefit both from the rationalization work carried out in the previous year, and from the effectiveness and efficiency resulting from the new organization in Italy which has now become operational.
-
The new organization was assessed as the most suitable, on the one hand, to best respond to the expected evolution of the domestic market, and on the other, to strengthen business integration with both the new companies included in the Group such as XCC S.r.l. and Design Group Italia S.r.l.

A PUBLIC COMPANY LISTED ON MTA – STAR SEGMENT


A SOLID CORPORATE GOVERNANCE
BOARD OF DIRECTORS BOARD OF STATUTORY AUDITORS
Independent Audit Firm: KPMG S.p.A.
| Chairman | Alessandro Mattiacci |
|---|---|
| Chief Executive Officer | Duccio Vitali |
| Deputy Chairman | Vittorio Massone |
| General Manager | Massimo Canturi |
| Director | Riccardo Lorenzini |
| Independent Director | Giorgia Albeltino |
| Independent Director | Giulia Bianchi Frangipane |
| Independent Director | Andrea Di Camillo |
| Independent Director | Serenella Sala |
| Chairman | Mauro Dario Bontempelli |
|---|---|
| Standing Auditor | Gabriele Gualeni |
| Standing Auditor | Daniela Bruno |
| Alternate Auditor | Marco Garrone |
| Alternate Auditor | Mara Sartori |

• The Board of Directors, the Board of Statutory Auditors and the Independent Audit Firm were appointed by the Shareholders' Meeting on June 25, 2017.
• Vittorio Massone was appointed by the Shareholders' Meeting on April 24, 2020.
• Massimo Canturi was appointed by the Shareholders' Meeting on April 26, 2021.

Alkemy innovation_enabler Via San Gregorio 34 20124 Milano, Italy Tel: +39 02 92894 1 - Fax: +39 02 92894 500 [email protected] Alkemy enabling evolution
INVESTOR RELATIONS [email protected]
